DKSC Stock Overview
Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Dakshidin Corporation, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0002 |
52 Week High | US$0.0009 |
52 Week Low | US$0.0002 |
Beta | 0 |
1 Month Change | -33.33% |
3 Month Change | -42.86% |
1 Year Change | -71.43% |
3 Year Change | -93.10% |
5 Year Change | -91.67% |
Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
DKSC | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | -20.0% | -0.06% | 2.1% |
1Y | -71.4% | 23.6% | 30.4% |
Return vs Industry: DKSC underperformed the US Pharmaceuticals industry which returned 23.6% over the past year.
Return vs Market: DKSC underperformed the US Market which returned 30.4% over the past year.
Price Volatility
DKSC volatility | |
---|---|
DKSC Average Weekly Movement | 41.1% |
Pharmaceuticals Industry Average Movement | 9.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: DKSC's share price has been volatile over the past 3 months.
Volatility Over Time: DKSC's weekly volatility has increased from 31% to 41% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Chris Haigh |
Dakshidin Corporation, Inc., through its subsidiaries, operates as a CBD/cannabis-based medical product company. It cultivates cannabis; and operates an online sales portal for CBD products. The company also manages distribution channel programs in the retail distribution, reselling, and direct sales market segments.
Dakshidin Corporation, Inc. Fundamentals Summary
DKSC fundamental statistics | |
---|---|
Market cap | US$1.12m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs DKSC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
DKSC income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did DKSC perform over the long term?
See historical performance and comparison